[go: up one dir, main page]

ES2194588B1 - Precursores opticamente puros de paroxetina. - Google Patents

Precursores opticamente puros de paroxetina.

Info

Publication number
ES2194588B1
ES2194588B1 ES200101648A ES200101648A ES2194588B1 ES 2194588 B1 ES2194588 B1 ES 2194588B1 ES 200101648 A ES200101648 A ES 200101648A ES 200101648 A ES200101648 A ES 200101648A ES 2194588 B1 ES2194588 B1 ES 2194588B1
Authority
ES
Spain
Prior art keywords
precursors
optically pure
paroxetine
pure paroxetine
hydroxymethylpiperidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101648A
Other languages
English (en)
Other versions
ES2194588A1 (es
Inventor
Miguel Bayod Jasanada
Victor M. Sanchez Pedregal
Vicente Gotor Santamaria
M. Rosario Brieva Collado
Gonzalo de Gonzalo Calvo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AsturPharma SA
Universidad de Oviedo
Original Assignee
AsturPharma SA
Universidad de Oviedo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AsturPharma SA, Universidad de Oviedo filed Critical AsturPharma SA
Priority to ES200101648A priority Critical patent/ES2194588B1/es
Priority to US10/192,768 priority patent/US20030018048A1/en
Priority to EP02380156A priority patent/EP1283200A3/en
Publication of ES2194588A1 publication Critical patent/ES2194588A1/es
Application granted granted Critical
Publication of ES2194588B1 publication Critical patent/ES2194588B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento biocatalítico de obtención de derivados ópticamente enriquecidos de trans-4-(4-fluorofenil)-3-hidroximetilpiperidinas basado en la resolución enzimática de precursores racémicos de fórmula III (donde R3 es preferentemente fenilo o bencilo) mediante acilación del hidroxilo. Dependiendo de la enzima y de las condiciones de reacción, se puede obtener cualquiera de los dos enantiómeros con alta pureza enantiomérica. Estos compuestos son importantes intermedios en la síntesis del antidepresivo paroxetina.
ES200101648A 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina. Expired - Fee Related ES2194588B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES200101648A ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.
US10/192,768 US20030018048A1 (en) 2001-07-13 2002-07-10 Optically pure paroxetine precursors
EP02380156A EP1283200A3 (en) 2001-07-13 2002-07-10 Optically pure paroxetine precursors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101648A ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.

Publications (2)

Publication Number Publication Date
ES2194588A1 ES2194588A1 (es) 2003-11-16
ES2194588B1 true ES2194588B1 (es) 2004-10-16

Family

ID=8498396

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101648A Expired - Fee Related ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.

Country Status (3)

Country Link
US (1) US20030018048A1 (es)
EP (1) EP1283200A3 (es)
ES (1) ES2194588B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2211327B1 (es) * 2002-12-18 2005-10-16 Astur Pharma S.A. Precursores opticamente puros de paroxetina.
ES2228274B1 (es) * 2003-09-24 2006-06-01 Astur Pharma, S.A. Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
EP2550873A1 (en) 2011-07-29 2013-01-30 AMBIENTE E NUTRIZIONE S.r.l. Process for the deep-freezing of a fluid food preparation
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
WO2023070605A1 (en) * 2021-10-29 2023-05-04 Trevena, Inc. Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220962B1 (hu) * 1989-11-13 2002-07-29 Pfizer Inc. Optikailag aktív 5-[3-(exo-biciklo[2.2.1]hept-2-il-oxi)-4-metoxi-fenil]-3,4,5,6-tetrahidropirimidin-2(1H)-on, enantiomere, valamint intermedierjeik
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
EP1119553A1 (en) * 1998-10-07 2001-08-01 Georgetown University Monomeric and dimeric heterocycles, and therapeutic uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CA en STN, AN 135:180691 & A. GOSWAMI et al. Organic Process Research and Development, Vol. 5, páginas 415-420, 2001, "Chemical and enzymatic resolution of (R,S)-N-(t-butoxycarbonyl)-3-hydroxymethylpiperidine". Resumen. *

Also Published As

Publication number Publication date
ES2194588A1 (es) 2003-11-16
EP1283200A3 (en) 2003-03-05
EP1283200A2 (en) 2003-02-12
US20030018048A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
FI92397B (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
DE69928821D1 (de) Auflösung von trans-2 (alkoxycarbonylethyl)-lactamen, nützlich bei der synthese von 1-(4-fluorophenyl)-3(r)-3(s)-hydroxy-3-(4-fluorophenyl)propyl]-4(s)-(4-hydroxyphenyl)-2-azetidinone
NO20052244D0 (no) Enantioselektiv fremgangsmate for fremstilling av begge enantiomerene av 10,11- dihydro-10-hydroksy-5H-dibenzo[b,f]- azepin-5-karboksamid og nye krystallformer derav
DE60001657D1 (de) Verfahren zur herstellung von n-(4-cyan-3-trifluormethylphenyl)-3-(4-flurophenylsulfonyl)-2-hydroxy-2-methylpropionamid
DK1756052T3 (da) Forbedret fremgangsmåde til at fremstille 3-hydroxy-4-hydroxymethyl-pyrrolidin-forbindelser
BR0317005A (pt) Processo para a preparação de compostos ativos opticamente puros
ES2194588B1 (es) Precursores opticamente puros de paroxetina.
ATE416158T1 (de) Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
ME00028B (me) Postupak za separaciju intermedijara koji može da se upotrebi za preparaciju escitaloprama
NO20062656L (no) Fremgangsmate for fremstilling av statiner
CY1106454T1 (el) Μεθοδος για την παρασκευη των εναντιομepων μορφων των παραγωγων 1,3-κυκλοεξανοδιολης cis-διαταξης
DE69634345D1 (de) Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen
MA24197A1 (fr) Nouvelles fungarrestines
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
EA200000127A1 (ru) Способ получения аминопроизводных алкилоксифуранона, получаемые этим способом соединения и применение этих соединений
PT1141374E (pt) Processo para a producao de derivados de 1-amino-4-(hidroximetil)ciclopent-2-eno opticamente activos
HUP9803034A2 (hu) Eljárás 1-(aminometil)-ciklohexán ecetsav előállítására és új köztitermékek
IT1188641B (it) Processo per la risoluzione enzimatica di 2-ammino-1-alcanoli racemi
ES2211327B1 (es) Precursores opticamente puros de paroxetina.
JPH05227991A (ja) 光学活性な３−ピロリジノール誘導体の製造法
DE602004014739D1 (de) Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate
DE60035194D1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
NO20022690D0 (no) Nye strukturelle analoger av Vitamin D
DK1368325T3 (da) Ny asymmetrisk fremgangsmåde til fremstilling af diarylmethylpiperazinderivater og hidtil ukendte asymmetriske diarylmethylaminer som mellemprodukter
DE50204211D1 (de) Verfahren zur enzymatischen Herstellung von enantiomerenreinen 1,3-Dioxolan-4-on- und 1,3-Oxathiolan-5-on-Derivaten

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031116

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2194588B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807